Induction of bax protein and degradation of lamin A during p53-dependent apoptosis induced by chemotherapeutic agents in human cancer cell lines

Biochemical Pharmacology

Volumn 57, Issue 2, 1999, Pages 143-154

  Ho, Yuan Soon ^a   Lee, Horng Mo ^a   Chang, Chuang Rung ^a   Lin, Jen Kun ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bax; Etoposide; Lamin A; p53; PARP

Indexed keywords

8 AZAGUANINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BROXURIDINE; BUDOTITANE; BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETHIDIUM BROMIDE; ETOPOSIDE; FLUOROURACIL; LAMIN A; METHOTREXATE; MITOMYCIN C; PROTEIN BAX; VINCRISTINE;

APOPTOSIS; CANCER CELL; CARCINOMA CELL; CELL FRACTIONATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVIEW;

EID: 0032927394     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00272-X     Document Type: Article

References (70)

1. Kerr J.F.R. Shrinkage necrosis A distinct mode of cellular death . J Pathol. 105:1971;13-20.
2. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis, a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
3. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
4. White E. Life, death and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
5. Ho Y.S., Wang Y.J., Lin J.K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog. 16:1996;20-31.
6. Ho Y.S., Lee H.M., Mou T.C., Wang Y.J., Lin J.K. Suppression of nitric oxide-induced apoptosis by L-N-acetyl-cysteine through modulation of glutathione, Bcl-2 and Bax proteins levels. Mol Carcinog. 19:1997;101-113.
7. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
8. Chen-Levy Z., Nourse J., Clear M.L. The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18). Mol Cell Biol. 9:1989;701-710.
9. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigations of the subcellular distribution of the Bcl-2 oncoprotein Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondria membranes . Cancer Res. 53:1993;4701-4714.
10. Kumar S. ICE-like protease in apoptosis. Trends Biochem Sci. 20:1995;198-202.
11. Fraser A., Evan G. A license to kill. Cell. 85:1996;781-784.
12. Earnshaw W.C., Takahashi A. ICE-related protease in apoptosis. Curr Opin Genet Dev. 6:1996;50-55.
13. Martin S.J., Green D.R. Protease activation during apoptosis Death by a thousand cuts? Cell. 82:1995;349-352.
14. Faucheu C., Diu A., Chan A.W.E., Blanchet A.M., Miossec C., Hervè F., Collard-Dutilleul V., Gu Y., Aldape R.A., Lippke J.A., Rocher C., Su MS-S., Livingston D.J., Hercend T., Lalanne J-L. A novel human protease similar to the interleukin-1 (IL-1)-β converting enzyme induces apoptosis in transfected cells. EMBO J. 14:1995;1914-1922.
15. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
16. Darmon A.J., Nicholson D.W., Bleackley R.C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B. Nature (London). 377:1995;446-448.
17. Quan L.T., Tewari M., O'Rourke K., Dixit V., Snipas S.J., Poirier G.G., Ray C., Pickup D.J., Salvesen G.S. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci USA. 93:1996;1972-1976.
18. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian IL-1-β-converting enzyme. Cell. 75:1993;641-652.
19. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
20. Fernandes-Alnemri T., Litwack G., Alnemri E.S. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55:1995;2737-2742.
21. Lazebnik Y.A., Takahashi A., Moir R.D., Goldman R.D., Poirier G.G., Kaufmann S.H., Earnshaw W.C. Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptosis execution. Proc Natl Acad Sci USA. 92:1995;9042-9046.
22. MacFarlane M., Cain K., Sun X.M., Alnemri E.S., Cohen G.M. Processing/activation of at least four IL-1β converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J Cell Biol. 137:1997;469-479.
23. Lazebnik Y.A., Kaufmann S.H., Desnoyers G.G., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
24. Patel T., Gores G.J., Kaufmann S.H. The role of proteases during apoptosis. FASEB J. 10:1996;587-597.
25. McKeon F. Nuclear lamin proteins Domains required for nuclear targeting, assembly, and cell-cycle-regulated dynamics . Curr Opin Cell Biol. 3:1991;82-86.
26. Gerace L., Burke B. Functional organization of the nuclear envelope. Annu Rev Cell Biol. 4:1988;335-374.
27. Earnshaw W.C. Nuclear changes in apoptosis. Curr Opin Cell Biol. 7:1995;337-343.
28. Rao L., Perez D., White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol. 135:1996;1441-1455.
29. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs A cautionary note . Cancer Res. 49:1989;5870-5878.
30. Lazebnik Y.A., Cole S., Cooke C.A., Nelson W.G., Earnshaw W.C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol. 123:1993;7-22.
31. Oberhammer F.A., Hochegger K., Froschl G., Tiefenbacher R., Pavelka M. The role of proteases during apoptosis. J Cell Biol. 126:1994;827-837.
32. Takahashi A., Alnemri E.S., Lazebnik Y.A., Fernandes-Alnemri T., Litwack G., Moir R.D., Goldman R.D., Poirier G.G., Kaufmann S.H., Earnshaw W.C. Cleavage of lamin A by Mch2α but not CPP32: Multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA. 93:1996;8395-8400.
33. Semple T.U., Quinn L.A., Woods L.K., Moore G.E. Lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxic model. Cancer Res. 38:1978;1345-1355.
34. Aden D.P., Fogel A., Plotkin S., Damjanov I., Knowles B.B. Controlled synthesis of HBs Ag in a differentiated human liver carcinoma-derived cell line. Nature. 282:1979;615-616.
35. Knowles B.B., Howe C.C., Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (Washington DC). 209:1980;497-499.
36. Darlington G.J., Kelly J.H., Buffone G.J. Growth and hepatospecific gene expression of human hepatoma cells in a defined medium. In Vitro Cell Dev Biol. 23:1987;349-354.
37. Bressac B., Galvin K.M., Liang T.J., Isselbacher K.J., Wands J.R., Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;1973-1977.
38. Niewolik D., Vojtesek B., Kovarik J. p53 derived from human tumor cell lines and containing distinct point mutations can be activated to bind its consensus target sequence. Oncogene. 10:1995;881-890.
39. Reed J.C., Meister L., Tanaka S., Cuddy M., Yum S., Geyer C., Pleasure D. Differential expression of bcl-2 proto-oncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 51:1991;6529-6538.
40. Blobel G., Potter V.R. Nuclei from rat liver Isolation method that combines purity with high yield . Science. 154:1966;1662-1665.
41. Schwaiger M., Herzog V., Neupert W. Characterization of translocation contact sites involved in the import of mitochondria proteins. J Cell Biol. 105:1987;235-246.
42. Kuo L.M., Davies H.C., Smith L. Monoclonal antibody to human cytochrome c effect on electron-transfer reactions . Biochim Biophys Acta. 848:1986;247-255.
43. Lamarre D., Talbot B., de Murcia G., Laplante C., Leduc Y., Mazen A., Poirier G.G. Structural and functional analysis of poly (ADP-ribose) polymerase An immunologic study . Biochim Biophys Acta. 950:1988;147-160.
44. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T-T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
45. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
46. Hsu Y.T., Wolter K.G., Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-xL during apoptosis. Proc Natl Acad Sci USA. 94:1997;3668-3672.
47. Jiang M.C., Yang-Yen H.F., Lin J.K., Yen J.J. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene. 13:1996;609-616.
48. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 139:1997;1281-1292.
49. Selvakumaran M., Lin H.K., Miyashita T., Wang H.G., Krajewski S., Reed J.C., Hoffman B., Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF-β1 a paradigm for distinct apoptotic pathways . Oncogene. 9:1994;1791-1798.
50. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., Fornace A.J. Jr. Induction of Bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9:1994;3743-3751.
51. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
52. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3135.
53. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
54. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
55. Kothakota S., Azuma T., Reinhard C., Kippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin Effector of morphological change in apoptosis . Science. 278:1997;294-298.
56. Wen L.P., Fahrni J.A., Troie S., Guan J.L., Orth K., Rosen G.D. Cleavage of focal adhesion kinase by caspase during apoptosis. J Biol Chem. 272:1997;26056-26061.
57. Compton M.M. A biochemical hallmark of apoptosis Internucleosomal degradation of the genome . Cancer Metastasis Rev. 11:1992;105-119.
58. Wyllie A.H., Morris R.G., Smith A.L., Dunlop D. Chromatin cleavage in apoptosis Association with condensed chromatin morphology and dependence on macromolecular synthesis . J Pathol. 142:1984;66-77.
59. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
60. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
61. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
62. Kroemer G., Zamzami N., Susin S.A. Mitochondrial control of apoptosis. Immunol Today. 18:1997;44-51.
63. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts Requirement for dATP and cytochrome c . Cell. 86:1996;147-157.
64. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2 Release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
65. Kluck R.M., Ella B.W., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria A primary site for Bcl-2 regulation of apoptosis . Science. 275:1997;1132-1136.
66. Emily H.Y.C., David G.K., Rollie J.C., Rajani R., Michael B.K., Atul B., Kazuyoshi U., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
67. Chittenden T., Flemington C., Houghton A.B., Ebb R.G., Gallo G.J., Elangovan B., Chinnadurai G., Lutz R.J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:1995;5589-5596.
68. Han J.P., Sabbatini D., Perez L., Rao D., Modha D., White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:1996;461-477.
69. Zha H., Fisk H.A., Yaffe M.P., Mahajan N., Herman B., Reed J.C. Structure-function comparisons of apoptosis protein Bax in yeast and mammalian cells. Mol Cell Biol. 16:1996;6494-6508.
70. Kitada S., Krajewski S., Miyashita T., Krajewska M., Reed J.C. γ-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene. 12:1996;187-192.